← FDA Drug Approvals (Drugs@FDA)

PRIMAXIN

NDA · New Drug Application · Sponsor: MERCK · Approved 1990-12-14

Drug application

FDA Application #

NDA050630

Application type

New Drug Application

Brand name

PRIMAXIN

Generic name

Cilastatin Sodium

Active ingredients

CILASTATIN SODIUM; IMIPENEM

Dosage form

POWDER

Route

INTRAMUSCULAR

Marketing status

Discontinued

Sponsor

MERCK

First approval

1990-12-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown